NASDAQ:SGRY Surgery Partners (SGRY) Stock Price, News & Analysis → Incredible Opportunity to Retire FAST! (From Crypto 101 Media) (Ad) Free SGRY Stock Alerts $27.77 +2.17 (+8.48%) (As of 05/7/2024 ET) Add Compare Share Share Today's Range$26.97▼$28.5550-Day Range$23.42▼$31.1952-Week Range$22.05▼$45.79Volume2.97 million shsAverage Volume923,113 shsMarket Capitalization$3.53 billionP/E RatioN/ADividend YieldN/APrice Target$43.63 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Surgery Partners alerts: Email Address Surgery Partners MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.88 Rating ScoreUpside/Downside57.1% Upside$43.63 Price TargetShort InterestBearish11.78% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.20Based on 17 Articles This WeekInsider TradingSelling Shares$477,225 Sold Last QuarterProj. Earnings Growth35.90%From $0.78 to $1.06 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.32 out of 5 starsMedical Sector295th out of 903 stocksGeneral Medical & Surgical Hospitals Industry4th out of 5 stocks 4.4 Analyst's Opinion Consensus RatingSurgery Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.88, and is based on 7 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageSurgery Partners has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Surgery Partners' stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted11.78% of the float of Surgery Partners has been sold short.Short Interest Ratio / Days to CoverSurgery Partners has a short interest ratio ("days to cover") of 9.4.Change versus previous monthShort interest in Surgery Partners has recently increased by 3.99%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldSurgery Partners does not currently pay a dividend.Dividend GrowthSurgery Partners does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SGRY. Previous Next 2.9 News and Social Media Coverage News SentimentSurgery Partners has a news sentiment score of 0.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.39 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 17 news articles for Surgery Partners this week, compared to 3 articles on an average week.Search Interest4 people have searched for SGRY on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows1 people have added Surgery Partners to their MarketBeat watchlist in the last 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Surgery Partners insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $477,225.00 in company stock.Percentage Held by InsidersOnly 2.60% of the stock of Surgery Partners is held by insiders.Read more about Surgery Partners' insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Surgery Partners are expected to grow by 35.90% in the coming year, from $0.78 to $1.06 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Surgery Partners is -277.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Surgery Partners is -277.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioSurgery Partners has a PEG Ratio of 2.24. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSurgery Partners has a P/B Ratio of 1.16. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Surgery Partners' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaIncredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide About Surgery Partners Stock (NASDAQ:SGRY)Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.Read More SGRY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SGRY Stock News HeadlinesMay 7, 2024 | markets.businessinsider.comSurgery Partners Boosts FY24 Outlook - UpdateMay 7, 2024 | msn.comSGRY Stock Earnings: Surgery Partners Beats EPS, Beats Revenue for Q1 2024May 7, 2024 | Priority Gold (Ad)The 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.May 7, 2024 | markets.businessinsider.comSurgery Partners Q1 Earnings SummaryMay 7, 2024 | msn.comSurgery Partners beats top-line and bottom-line estimates; raise FY24 outlookMay 7, 2024 | finance.yahoo.comSurgery Partners Inc (SGRY) Q1 2024 Earnings: Revenue and EBITDA Surpass Expectations,May 7, 2024 | finance.yahoo.comSurgery Partners Inc (SGRY) Q1 2024 Earnings: Revenue and EBITDA Surpass Expectations, ...May 7, 2024 | globenewswire.comSurgery Partners, Inc. Announces First Quarter 2024 ResultsMay 7, 2024 | Priority Gold (Ad)The 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.May 6, 2024 | msn.comSurgery Partners Q1 2024 Earnings PreviewMay 5, 2024 | americanbankingnews.comSurgery Partners (SGRY) Set to Announce Quarterly Earnings on TuesdayMay 4, 2024 | americanbankingnews.comSurgery Partners (NASDAQ:SGRY) Earns "Buy" Rating from BenchmarkMay 3, 2024 | americanbankingnews.comSurgery Partners, Inc. (NASDAQ:SGRY) Given Consensus Rating of "Moderate Buy" by BrokeragesApril 24, 2024 | finance.yahoo.comShould You Invest in Surgery Partners (SGRY)?April 18, 2024 | globenewswire.comSurgery Partners, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call DetailsApril 17, 2024 | nasdaq.comSurgery Partners Enters Oversold Territory (SGRY)March 29, 2024 | markets.businessinsider.comSurgery Partners: A Buy Rating Amidst Underperformance and Growth PotentialMarch 26, 2024 | seekingalpha.comSurgery Partners to offer $600M senior unsecured notesMarch 26, 2024 | globenewswire.comSurgery Partners, Inc. Announces Pricing of New Senior Notes OfferingMarch 26, 2024 | globenewswire.comSurgery Partners, Inc. Announces New Senior Notes OfferingMarch 25, 2024 | finance.yahoo.comInvestors Met With Slowing Returns on Capital At Surgery Partners (NASDAQ:SGRY)March 7, 2024 | finance.yahoo.comInsider Sell: CFO David Doherty Sells 3,426 Shares of Surgery Partners Inc (SGRY)March 6, 2024 | realmoney.thestreet.comSurgery Partners initiated with neutral view at BarclaysMarch 1, 2024 | finance.yahoo.comSurgery Partners, Inc. (NASDAQ:SGRY) Q4 2023 Earnings Call TranscriptMarch 1, 2024 | ca.finance.yahoo.comSGRY Mar 2024 30.000 putMarch 1, 2024 | markets.businessinsider.comSurgery Partners: Maintaining Buy Rating with Slight EBITDA Adjustment and Price Target IncreaseFebruary 28, 2024 | seekingalpha.comSurgery Partners, Inc. (SGRY) Q4 2023 Earnings Call TranscriptSee More Headlines Receive SGRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/26/2024Today5/07/2024Next Earnings (Confirmed)5/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry General medical & surgical hospitals Sub-IndustryN/A Current SymbolNASDAQ:SGRY CUSIPN/A CIK1638833 Webwww.surgerypartners.com Phone(615) 234-5900Fax615-234-5998Employees13,500Year FoundedN/APrice Target and Rating Average Stock Price Target$43.63 High Stock Price Target$50.00 Low Stock Price Target$35.00 Potential Upside/Downside+57.1%Consensus RatingModerate Buy Rating Score (0-4)2.88 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)($0.10) Trailing P/E RatioN/A Forward P/E Ratio35.60 P/E Growth2.24Net Income$-11,900,000.00 Net Margins-0.43% Pretax Margin4.92% Return on Equity3.65% Return on Assets1.62% Debt Debt-to-Equity Ratio0.89 Current Ratio1.71 Quick Ratio1.57 Sales & Book Value Annual Sales$2.74 billion Price / Sales1.29 Cash Flow$2.03 per share Price / Cash Flow13.66 Book Value$23.99 per share Price / Book1.16Miscellaneous Outstanding Shares127,100,000Free Float123,797,000Market Cap$3.53 billion OptionableOptionable Beta2.75 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Wayne Scott DeVeydt (Age 54)Executive Chairman Comp: $250kMr. J. Eric Evans (Age 47)CEO & Director Comp: $2.06MMr. David T. Doherty (Age 52)Executive VP & CFO Comp: $1.12MMs. Jennifer B. Baldock (Age 53)Executive VP and Chief Administrative & Development Officer Comp: $1.11MMr. Bradley R. Owens (Age 54)President of National Group Comp: $807.6kMs. Marissa A. Brittenham (Age 39)Executive VP & Chief Strategy Officer Comp: $677.29kMr. Neil C. Zieselman (Age 48)Senior Vice President of Corporate Finance & Controller Mr. Varun GadhokSenior VP & Chief Information OfficerMs. Roxanne WomackSenior VP & Chief Compliance OfficerMs. Danielle Burkhalter (Age 39)Executive VP & Chief Human Resources Officer More ExecutivesKey CompetitorsCommunity Health SystemsNYSE:CYHTenet HealthcareNYSE:THCUniversal Health ServicesNYSE:UHSSotera HealthNASDAQ:SHCBausch Health CompaniesNYSE:BHCView All CompetitorsInsiders & InstitutionsSG Americas Securities LLCSold 13,563 shares on 5/7/2024Ownership: 0.005%BNP Paribas Financial MarketsBought 106,054 shares on 5/1/2024Ownership: 0.331%Mirae Asset Global Investments Co. Ltd.Sold 11,837 shares on 5/1/2024Ownership: 0.018%Capstone Investment Advisors LLCBought 2,551 shares on 5/1/2024Ownership: 0.007%Principal Financial Group Inc.Bought 1,409 shares on 4/29/2024Ownership: 0.008%View All Insider TransactionsView All Institutional Transactions SGRY Stock Analysis - Frequently Asked Questions Should I buy or sell Surgery Partners stock right now? 8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last twelve months. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SGRY shares. View SGRY analyst ratings or view top-rated stocks. What is Surgery Partners' stock price target for 2024? 8 Wall Street analysts have issued twelve-month price targets for Surgery Partners' shares. Their SGRY share price targets range from $35.00 to $50.00. On average, they expect the company's stock price to reach $43.63 in the next twelve months. This suggests a possible upside of 57.1% from the stock's current price. View analysts price targets for SGRY or view top-rated stocks among Wall Street analysts. How have SGRY shares performed in 2024? Surgery Partners' stock was trading at $31.99 at the start of the year. Since then, SGRY stock has decreased by 13.2% and is now trading at $27.77. View the best growth stocks for 2024 here. When is Surgery Partners' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024. View our SGRY earnings forecast. How were Surgery Partners' earnings last quarter? Surgery Partners, Inc. (NASDAQ:SGRY) announced its earnings results on Monday, February, 26th. The company reported $0.44 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.37 by $0.07. The firm had revenue of $735.40 million for the quarter, compared to analysts' expectations of $741.93 million. Surgery Partners had a positive trailing twelve-month return on equity of 3.65% and a negative net margin of 0.43%. The company's revenue for the quarter was up 4.0% compared to the same quarter last year. During the same period in the prior year, the business posted $0.22 earnings per share. What ETFs hold Surgery Partners' stock? ETFs with the largest weight of Surgery Partners (NASDAQ:SGRY) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), BlackRock Future Innovators ETF (BFTR) and Harbor Corporate Culture Small Cap ETF (HAPS).iShares U.S. Healthcare Providers ETF (IHF). What guidance has Surgery Partners issued on next quarter's earnings? Surgery Partners issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $3.0 billion-, compared to the consensus revenue estimate of $3.0 billion. What is Eric Evans' approval rating as Surgery Partners' CEO? 7 employees have rated Surgery Partners Chief Executive Officer Eric Evans on Glassdoor.com. Eric Evans has an approval rating of 86% among the company's employees. What other stocks do shareholders of Surgery Partners own? Based on aggregate information from My MarketBeat watchlists, some companies that other Surgery Partners investors own include Sorrento Therapeutics (SRNE), Rigel Pharmaceuticals (RIGL), Ardelyx (ARDX), Glu Mobile (GLUU), Ocular Therapeutix (OCUL), Sangamo Therapeutics (SGMO), Xilinx (XLNX), Allena Pharmaceuticals (ALNA), Editas Medicine (EDIT) and Maxar Technologies (MAXR). Who are Surgery Partners' major shareholders? Surgery Partners' stock is owned by a variety of retail and institutional investors. Top institutional investors include WCM Investment Management LLC (0.40%), BNP Paribas Financial Markets (0.33%), Wesbanco Bank Inc. (0.02%), Mirae Asset Global Investments Co. Ltd. (0.02%), Los Angeles Capital Management LLC (0.02%) and Cannon Global Investment Management LLC (0.02%). Insiders that own company stock include Andrew T Kaplan, Anthony Taparo, Bradley R Owens, Brent Turner, Danielle Burkhalter, David T Doherty, George Goodwin, Harrison R Bane, Jason Eric Evans, Jennifer Baldock, Laura L Brocklehurst, Laura L Brocklehurst, Marissa Brittenham, Teresa Deluca and Wayne S Deveydt. View institutional ownership trends. How do I buy shares of Surgery Partners? Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SGRY) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsObama’s Forever Term [exposed]Porter & CompanyThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surgery Partners, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.